Alex Pharma’s profits increase by 34.68% YoY in 9 months: Egypt

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company

Staff Writer, Arab Finance

May 15, 2023

PHOTO

Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) posted a 34.68% year-on-year (YoY) in net profit after tax in the first nine months of fiscal year (FY) 2022/2023, according to financial statements filed to the Egyptian Exchange (EGX) on May 14th.

The company’s net profit after tax jumped to EGP 108.222 million in the nine-month period ended March 31st 2023 from EGP 80.357 million in the year-ago period.

Revenue grew 41.26% YoY to EGP 1.190 billion in the July 2022-March 2023 period, from EGP 842.626 million in a FY earlier.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.